Home › Steatotic Liver Disease › Connecticut
Steatotic Liver Disease clinical trials in Connecticut
5 studies for Steatotic Liver Disease are looking for participants at sites in Connecticut.
Cities in Connecticut
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Medical Research Center of Connecticut, Hamden
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, New Haven
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
- Yale New Haven Hospital, New Haven
RecruitingObservational study
Ages 12 to 18 · All sexes · Updated Jul 30, 2026 · NCT04634643Reversal of Lipid-Induced Insulin Resistance
- Yale Center for Clinical Investigation HRU, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Jun 22, 2026 · NCT02193295Digoxin In NASH (CODIN)
- Yale New Haven Health, New Haven
- Yale New Haven Hospital, New Haven
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated May 26, 2026 · NCT06588699From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.